Multi-Target Modulation Of The Homologous Recombination Pathway By Resveratrol Promotes DNA Damage Repair In POI: Integrated Network Pharmacology, Molecular Dynamics Simulation, And Experimental Validation
Premature ovarian insufficiency (POI) is a challenging condition marked by hormone imbalances and the loss of ovarian follicles. Researchers have been exploring potential treatments, and a natural compound called resveratrol, known for its antioxidant and anti-aging properties, has shown promise. This recent study delved into how resveratrol might work at a molecular level to combat POI.
Using advanced computational techniques, including network pharmacology and molecular simulations, scientists identified several key biological targets that resveratrol interacts with in the context of POI. These interactions were found to be crucial for processes like reproductive system development, DNA repair, and cellular aging.
To confirm these computational predictions, experiments were conducted using animal models of POI and ovarian cells. The results showed that resveratrol indeed improved ovarian health and hormone levels. More importantly, it was discovered that resveratrol enhances the cell’s ability to repair damaged DNA through a vital process called homologous recombination. This was evidenced by an increased presence of a key repair protein (RAD51) at DNA damage sites and a reduction in markers of DNA damage.
These findings provide a strong scientific basis for the potential use of resveratrol as a therapeutic agent for POI, highlighting its role in bolstering the body’s natural DNA repair mechanisms.
Source: link to paper